Epirubicin and docetaxel with or without capecitabine as neoadjuvant treatment for early breast cancer: final results of a randomized phase III study (ABCSG-24)

Steger, GG, Greil, R, Lang, A, Rudas, M, Fitzal, F, Mlineritsch, B, Hartmann, BL, Bartsch, R, Melbinger, E, Hubalek, M, Stöger, H, Dubsky, P, Ressler, S, Petzer, AL, Singer, CF, Muss, C, Jakesz, R, Gampenrieder, SP, Zielinski, CC, Fesl, C and Gnant, M (2014) Epirubicin and docetaxel with or without capecitabine as neoadjuvant treatment for early breast cancer: final results of a randomized phase III study (ABCSG-24). Ann Oncol..

Full text not available from this repository.

Item Type:	Fachpublikation (peer reviewed)
Divisions:	Ordensklinikum Linz Barmherzige Schwestern > Allgemeinchirurgie mit Viszeralchirurgie
Depositing User:	Judith Brandstetter
Date Deposited:	16 Jun 2014 07:30
Last Modified:	17 Feb 2025 09:31
URI:	https://eprints.vinzenzgruppe.at/id/eprint/7136

Actions (login required)

View Item